References
- Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. 2003. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett. 555(3):597–600.
- Chakraborty K, Francis P. 2021. Clathriolide from marine demosponge Clathria (Thalysias) vulpina (Lamarck, 1814): Previously undescribed macrocylic lactone with attenuating potential against angiotensin converting enzyme. Nat Prod Res.:1–9. [published online ahead of print, 2021 Feb 23]. doi: 10.1080/14786419.2021.1887177.
- Chakraborty K, Joy M. 2017. Anti-diabetic and anti-inflammatory activities of commonly available cephalopods. Int J Food Prop. 20(7):1655–1665.
- Chakraborty K, Krishnan S, Joy M. 2019. Macrocyclic lactones from seafood Amphioctopus neglectus: Newly described natural leads to attenuate angiotensin-II induced cardiac hypertrophy. Biomed Pharmacother. 110:155–167.
- Choi SI, Hwang SW. 2018. Depolarizing effectors of bradykinin signaling in nociceptor excitation in pain perception. Biomol Ther (Seoul). 26(3):255–267.
- Erickson KL, Beutler JA, Cardellina JH, II, Boyd MR. 1997. Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp. J Org Chem. 62(23):8188–8192.
- FAO, The State of World Fisheries and Aquaculture. 2017. Globefish highlights: A quarterly update on sea food markets. Quarterly issue, including Jan—Sept 2016 Statistics. Food and Agriculture Organisation of the United Nations, 2017, p. 26.
- Francis P, Chakraborty K. 2021. Stomopnolides A-B from echinoidea sea urchin Stomopneustes variolaris: Prospective natural anti-inflammatory leads attenuate pro-inflammatory 5-lipoxygenase. Nat Prod Res. 35(22):4235–4247.
- Frank AT, Farina NS, Sawwan N, Wauchope OR, Qi M, Brzostowska EM, Chan W, Grasso FW, Haberfield P, Greer A. 2007. Natural macrocyclic molecules have a possible limited structural diversity. Mol Divers. 11(3-4):115–118.
- Hickford SJ, Blunt JW, Munro MH. 2009. Antitumour polyether macrolides: Four new halichondrins from the New Zealand deep-water marine sponge Lissodendoryx sp. Bioorg Med Chem. 17(6):2199–2203.
- Huang C-Y, Wen CL, Lu Y-L, Lin YS, Chen LG, Hou W. 2010. Antihypertensive activities of extracts from tissue cultures of Vitis thunbergii var. taiwaniana. Bot Stud. 51(3):317–324.
- Huryn DM, Wipf P. 2014. Natural product chemistry and cancer drug discovery. In: Neidle S, editor. Cancer drug design and discovery. 2nd ed. San Diego: Academic Press; p. 91–120.
- Hwang BS, Kim HS, Yih W, Jeong EJ, Rho JR. 2014. Acuminolide A: Structure and bioactivity of a new polyether macrolide from dinoflagellate Dinophysis acuminata. Org Lett. 16(20):5362–5365.
- Joy M, Chakraborty K. 2017. First report of two new antioxidative meroterpeno 2H-pyranoids from short-necked yellow-foot clam Paphia malabarica (family: Veneridae) with bioactivity against pro-inflammatory cyclooxygenases and lipoxygenase. Nat Prod Res. 31(6):615–625.
- Krishnan S, Chakraborty K. 2019. Functional properties of ethyl acetate-methanol extract of commonly edible molluscs. J. Aquat. Food Prod. T. 28 (7):1–14.
- Kubinyi H. 1979. Nonlinear dependence of biological activity on hydrophobic character: The bilinear model. Farmaco Sci. 34(3):248–276.
- Kujawski J, Popielarska H, Myka A, Drabińska B, Bernard M. 2012. The log P parameter as a molecular descriptor in the computer-aided drug design-an overview. CMST. 18(2):81–88.
- Kumar KA, Jagannath P, Saleshier MF. 2018. Discovery of novel flavonoid analogues as angiotensin converting enzyme inhibitors on pharamcophore modelling and virtual screening techniques. Res J Pharm Technol. 11(10):4370–4378.
- Lee DH, Kim JH, Park JS, Choi YJ, Lee JS. 2004. Isolation and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from the edible mushroom Tricholoma giganteum. Peptides. 25(4):621–627.
- Li G-H, Le G-W, Shi Y-H, Shrestha S. 2004. Angiotensin I–converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr Res. 24(7):469–486.
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46(1-3):3–26.
- Litaudon M, Hickford SJ, Lill RE, Lake RJ, Blunt JW, Munro MH. 1997. Antitumor polyether macrolides: New and hemisynthetic halichondrins from the New Zealand deep-water sponge Lissodendoryx sp. J Org Chem. 62(6):1868–1871.
- Manning RD Jr, Tian N, Meng S. 2005. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 25(4):311–317.
- Natesh R, Schwager SLU, Evans HR, Sturrock ED, Acharya KR. 2004. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry. 43(27):8718–8724. doi:10.1021/bi049480n. 15236580.
- Oguchi K, Tsuda M, Iwamoto R, Okamoto Y, Endo T, Kobayashi J, Ozawa T, Masuda A. 2007. Amphidinolides B6 and B7, cytotoxic macrolides from a symbiotic dinoflagellate Amphidinium species. J Nat Prod. 70(10):1676–1679.
- Safaeian L, Emami R, Hajhashemi V, Haghighatian Z. 2018. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats. Biomed Pharmacother. 100:147–155.
- Salas S, Chakraborty K. 2018. An unreported polyether macrocyclic lactone with antioxidative and anti-lipoxygenase activities from the Babylonidae gastropod mollusc Babylonia spirata. Med Chem Res. 27(11–12):2446–2453.
- Salas S, Chakraborty K. 2020. Polyether macrocyclic polyketide from the muricid gastropod Chicoreus ramosus attenuates pro-inflammatory 5-lipoxygenase. Med Chem Res. 29(11):1976–1985.
- Shionoiri H, Shigemasa T, Takasaki I. 1997. Angiotensin-converting enzyme inhibitors: Recent therapeutic aspect. Nihon Rinsho. 55(8):2067–2074.
- Wijesekara I, Kim SK. 2010. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Mar Drugs. 8(4):1080–1093.
- Zhang H, Zou J, Yan X, Chen J, Cao X, Wu J, Liu Y, Wang T. 2021. Marine-derived macrolides 1990–2020: an overview of chemical and biological diversity. Mar Drugs. 19(4):180.